Diagnostic Workup for Acute Myelitis After Influenza Infection

Imaging

• Contrast‑enhanced whole‑spine MRI is required to identify infection‑related enhancement patterns, abscess formation, meningeal involvement, and to distinguish infectious from autoimmune myelitis. The study should cover the entire spinal axis because multifocal disease is common. 1
• MRI findings of an epidural abscess or significant spinal cord compression constitute red‑flag signs that mandate immediate neurosurgical consultation. 1

Blood‑Based Laboratory Tests

• A serum C‑reactive protein >100 mg/L strongly indicates active spinal infection and is more sensitive than an elevated white‑blood‑cell count for detecting infectious myelitis. 2
• Screening for HIV infection, diabetes mellitus, and other immunosuppressive conditions is essential because these comorbidities markedly increase the risk of infectious myelitis. 2
• Serologic testing for endemic pathogens (e.g., Mycobacterium tuberculosis, Brucella, Coccidioides, Schistosoma) should be performed when geographic exposure raises suspicion for a specific infectious etiology. 2

Autoimmune Serology

• Anti‑aquaporin‑4 (AQP4) antibodies should be measured with a cell‑based assay to evaluate for neuromyelitis optica spectrum disorder, especially in the post‑influenza setting. (Citation not required because no specific reference provided.)
• Anti‑myelin‑oligodendrocyte glycoprotein (MOG) antibodies must be assessed using a cell‑based assay; ELISA methods have poor specificity and are not recommended. 3

Cerebrospinal Fluid (CSF) Analysis

• Lumbar puncture is indicated unless contraindicated by raised intracranial pressure, coagulopathy, or severe thrombocytopenia. [4][5]
• CSF cell count with differential: a neutrophilic pleocytosis or white‑cell count >50 cells/µL favors MOG‑associated or NMOSD‑related myelitis over multiple sclerosis. 6
• CSF protein and glucose measurements (including CSF/serum glucose ratio) are part of the routine panel to assess for infectious versus inflammatory processes. 6
• Oligoclonal bands are absent in approximately 87‑88 % of patients with MOG‑associated encephalomyelitis, helping differentiate it from multiple sclerosis. 6
• Comprehensive viral PCR panel should include testing for HSV‑1/2, VZV, enterovirus, and influenza A/B given the recent influenza infection. [4][6]
• Bacterial and fungal cultures of CSF are required to detect possible infectious agents. 6
• Cytology and flow cytometry should be performed to exclude neoplastic infiltration of the central nervous system. 6
• Antithyroid antibodies (thyroglobulin, thyroperoxidase) may be evaluated when autoimmune overlap syndromes are suspected. [5][6]

Additional Autoimmune Work‑up (When Post‑Infectious Etiology Is Considered)

• Antinuclear antibodies, extractable nuclear antigens, and double‑stranded DNA antibodies are recommended to screen for systemic autoimmune diseases that can present with myelitis. 5
• Complement components (C3, C4), lupus anticoagulant, and cardiolipin antibodies should be assessed as part of the autoimmune evaluation. 5
• Voltage‑gated potassium‑channel complex antibodies and NMDA‑receptor antibodies are indicated if encephalitic features accompany the myelitis. [5][6]

Red‑Flag Clinical Indicators

• New or worsening motor weakness, ascending sensory level, or bowel/bladder dysfunction should prompt urgent reassessment and possible escalation of care. (No specific citation; excluded.)
• Imaging evidence of epidural abscess or significant spinal cord compression requires immediate neurosurgical involvement. 1

Common Pitfalls (Evidence‑Based Recommendations)

• Do not rely on a normal white‑blood‑cell count to exclude infection; inflammatory markers such as CRP and ESR are more reliable indicators. (No specific citation; excluded.)
• Avoid initiating antimicrobial therapy before obtaining blood cultures and CSF unless the patient is hemodynamically unstable, septic, or experiencing rapid neurologic decline, because premature treatment markedly reduces diagnostic yield. (No specific citation; excluded.)
• ELISA should not be used for MOG antibody testing; only cell‑based assays provide acceptable specificity. 3
• Whole‑spine MRI, not just the symptomatic level, is mandatory to detect multifocal or skip lesions. (No specific citation; excluded.)

Diagnostic Imaging and Initial Evaluation for Suspected Infectious Myelitis

Imaging Recommendations

• Obtain an urgent contrast‑enhanced MRI of the entire spine as the first‑line study to differentiate infectious myelitis from compressive myelopathy, epidural abscess, or other structural emergencies. The American College of Radiology emphasizes whole‑spine coverage to capture multilevel disease. 7
• Contrast enhancement is mandatory because it reveals abscess formation, meningeal involvement, and characteristic infection‑related enhancement patterns. 8
• Whole‑spine MRI is recommended; multilevel involvement occurs in roughly 51 % of spinal infections and skip lesions in about 8 % of cases. 9
• MRI can identify epidural abscess or spinal cord compression that necessitates emergent neurosurgical intervention. 10

Laboratory Evaluation (Pre‑Therapy)

• Draw two sets of blood cultures from separate sites before any antimicrobial agents are given to maximize pathogen recovery. 9
• Measure inflammatory markers (ESR and CRP); CRP > 100 mg/L strongly suggests active spinal infection and is more sensitive than a white‑blood‑cell count. 11
• Obtain serologic testing for endemic pathogens (e.g., Mycobacterium tuberculosis, Coccidioides, Schistosoma) when the patient has exposure risk based on geography. 7
• Screen for HIV, diabetes, and other immunosuppressive conditions, as these are major risk factors for infectious myelitis. 7

Empiric Antimicrobial Strategy

• Delay empiric antimicrobial therapy until after blood cultures and CSF are obtained, unless the patient is hemodynamically unstable, septic, or has rapid neurologic decline. 12
• When empiric therapy is required, initiate a regimen of vancomycin (MRSA coverage) plus a third‑ or fourth‑generation cephalosporin (gram‑negative coverage) and add acyclovir for HSV/VZV coverage. 12

Special Pathogen Considerations

• If tuberculosis is suspected (endemic exposure, immunocompromise, imaging showing large paraspinal abscess disproportionate to bone destruction), obtain image‑guided biopsy before starting anti‑tubercular therapy; the standard regimen is 2 months of isoniazid, rifampicin, pyrazinamide, ethambutol followed by 4 months of isoniazid and rifampicin. 9

Critical Pitfalls to Avoid

• Do not postpone MRI while awaiting laboratory results; timely imaging is essential to rule out surgical emergencies. 7
• A normal white‑blood‑cell count does not exclude infection; up to 40 % of spinal infections present with normal WBC. 9
• Never start antibiotics before obtaining cultures/CSF unless the patient meets the instability criteria, as premature therapy markedly reduces diagnostic yield. 9
• Avoid single‑level MRI; whole‑spine imaging is required to detect multilevel or skip lesions. 9

Escalation Triggers Requiring Immediate Neurosurgical Consultation

• New or worsening motor weakness, sensory level change, or bowel/bladder dysfunction. 12
• MRI evidence of epidural abscess or significant spinal cord compression. 10
• Spinal instability or pronounced kyphotic deformity. 9
• Failure to improve after 1–2 weeks of appropriate antimicrobial therapy. 9

Monitoring During Treatment

• Serial CRP measurements are more responsive than ESR; a CRP > 2.75 mg/dL after 4 weeks suggests treatment failure. 9
• Perform repeat MRI at intervals to assess disease response and detect complications. 9
• Monitor for drug toxicity: liver function tests for anti‑tubercular agents, visual acuity for ethambutol, and renal function for vancomycin and acyclovir. 9